PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 11040177-7 2000 C-reactive protein levels significantly decreased in the methylprednisolone group but not in the heparin group. Methylprednisolone 57-75 C-reactive protein Homo sapiens 0-18 23826449-7 2013 Less than 24 h after methylprednisolone administration, the QRS width decreased significantly from 0.44 s to 0.18 s. In addition, CK and CRP levels declined sharply, which is associated with hemodynamic improvement. Methylprednisolone 21-39 C-reactive protein Homo sapiens 137-140 17379997-11 2007 Steroid therapy including methylprednisolone pulse therapy (500 mg/day, 3 days) and 2 courses of plasma exchange were effective in reducing the fever, anti-GBM antibody titer and C-reactive protein level. Methylprednisolone 26-44 C-reactive protein Homo sapiens 179-197 24387072-3 2002 Methylprednisolone pulse therapy was effective in improving the serositis and normalizing CRP. Methylprednisolone 0-18 C-reactive protein Homo sapiens 90-93 11749774-12 2001 After administration of methylprednisolone or aprotinin, leukocyte CD11b expression, plasma IL-6, IL-8, C-reactive protein levels, and MPO activity decreased by different extent. Methylprednisolone 24-42 C-reactive protein Homo sapiens 104-122 24959459-8 2014 Fatigue (p = 0.002) and changes in CRP (p=0.001) were significantly lower in MP group. Methylprednisolone 77-79 C-reactive protein Homo sapiens 35-38 21406101-11 2011 Interleukin (IL)-6 and C-reactive protein (CRP) showed a significantly quicker decrease after 24 h of treatment among patients treated with MPDN. Methylprednisolone 140-144 C-reactive protein Homo sapiens 23-41 21406101-11 2011 Interleukin (IL)-6 and C-reactive protein (CRP) showed a significantly quicker decrease after 24 h of treatment among patients treated with MPDN. Methylprednisolone 140-144 C-reactive protein Homo sapiens 43-46 17588396-8 2007 Methylprednisolone attenuated postoperative tumor necrosis factor-alpha, interleukin 6, interleukin 8, and C-reactive protein levels while increasing interleukin 10 release. Methylprednisolone 0-18 C-reactive protein Homo sapiens 107-125 12926656-4 2003 The acute (as measured by C-reactive protein, CRP) and chronic (by erythrocyte sedimentation rate, ESR) phases of RF+ RA were suppressed by pulse intravenous (IV) combination of low dose methylprednisolone (MPS) + cyclophosphamide (CYC) for 3 consecutive days and weekly intravenous methotrexate (MTX) with simultaneous oral cyclosporine (CSA) + mycophenolate mofetil (MPM). Methylprednisolone 187-205 C-reactive protein Homo sapiens 26-44 12926656-4 2003 The acute (as measured by C-reactive protein, CRP) and chronic (by erythrocyte sedimentation rate, ESR) phases of RF+ RA were suppressed by pulse intravenous (IV) combination of low dose methylprednisolone (MPS) + cyclophosphamide (CYC) for 3 consecutive days and weekly intravenous methotrexate (MTX) with simultaneous oral cyclosporine (CSA) + mycophenolate mofetil (MPM). Methylprednisolone 187-205 C-reactive protein Homo sapiens 46-49 11102253-7 2000 Forty-eight hours after randomization, mean C-reactive protein levels decreased by 2.6 mg. l(-1)in the methylprednisolone group, but increased by 1.6 mg. l(-1)in the placebo group (P=0.03). Methylprednisolone 103-121 C-reactive protein Homo sapiens 44-62 31222540-13 2019 Post-operative C-reactive protein level was significantly less in the methylprednisolone group (p < 0.001). Methylprednisolone 70-88 C-reactive protein Homo sapiens 15-33 9589022-8 1998 On methylprednisolone (1 mg/kg daily) the eosinophil and platelet counts became normal within 5 days and erythrocyte sedimentation rate and the level of C-reactive protein fell. Methylprednisolone 3-21 C-reactive protein Homo sapiens 153-171 35194371-4 2022 Conclusions: Treatment of severe COVID-19 pneumonia, Patients who were mechanically ventilated with methylprednisolone infusion 2 mg/kg/day for 10 days versus dexamethasone 6 mg for 10 days showed a statistically significant improvement in the MV days and length of stay in the intensive care unit, together with the overall mortality and severity inflammatory markers of cytokine storm c-reactive protein (CRP), D-dimer, ferritin, LDH, and N:L ratio. Methylprednisolone 100-118 C-reactive protein Homo sapiens 387-405 35194371-4 2022 Conclusions: Treatment of severe COVID-19 pneumonia, Patients who were mechanically ventilated with methylprednisolone infusion 2 mg/kg/day for 10 days versus dexamethasone 6 mg for 10 days showed a statistically significant improvement in the MV days and length of stay in the intensive care unit, together with the overall mortality and severity inflammatory markers of cytokine storm c-reactive protein (CRP), D-dimer, ferritin, LDH, and N:L ratio. Methylprednisolone 100-118 C-reactive protein Homo sapiens 407-410 33876782-11 2021 C-reactive protein levels less than 60mg/L by day 3 was seen in 17(74%) in methylprednisolone group and 2 (25%) in IVIG group (P=0.014). Methylprednisolone 75-93 C-reactive protein Homo sapiens 0-18 33344594-9 2020 In case of deterioration, considering the hyperinflammatory state of the patients, methylprednisolone was intravenously administered at 0.75-1.5 mg/kg/d, usually for less than 14 d. Patient vital signs and oxygenation were closely monitored, in combination with imaging and routine blood tests such as C-reactive protein, biochemical indicators (liver and kidney function, myocardial enzymes, electrolytes, etc. Methylprednisolone 83-101 C-reactive protein Homo sapiens 302-320 35097067-9 2022 During the treatment, the lymphocyte count, ESR, IL-6, serum ferritin, LDH, CK-MB, hs-CRP and D-dimer levels all improved gradually, indicating that both Arbidol and methylprednisolone therapy were contributed to improving the condition of COVID-19 patients. Methylprednisolone 166-184 C-reactive protein Homo sapiens 86-89 35005432-11 2022 Methylprednisolone treatment also reduced the C-reactive protein levels, compared to the standard care group on day 7. Methylprednisolone 0-18 C-reactive protein Homo sapiens 46-64 34033648-20 2021 CONCLUSIONS: In this study, the treatment of severe Covid-19 Pneumonia with high-dose methylprednisolone for three days followed by oral prednisone for 14 days, compared with 6 mg dexamethasone for 7 to 10 days, statistically significantly decreased the recovery time, the need for transfer to intensive care and the severity markers C-reactive protein (CRP), D-dimer and LDH. Methylprednisolone 86-104 C-reactive protein Homo sapiens 334-352 34033648-20 2021 CONCLUSIONS: In this study, the treatment of severe Covid-19 Pneumonia with high-dose methylprednisolone for three days followed by oral prednisone for 14 days, compared with 6 mg dexamethasone for 7 to 10 days, statistically significantly decreased the recovery time, the need for transfer to intensive care and the severity markers C-reactive protein (CRP), D-dimer and LDH. Methylprednisolone 86-104 C-reactive protein Homo sapiens 354-357 32940751-6 2021 RESULTS: Following administration of methylprednisolone were significantly lower levels of CRP on all the four post-operative days; leukocytosis on the second day; the VAS/NRS score at rest after six, 12, and 18 hours post-operatively, diminished the dose of parenteral opioid preparations (oxycodone hydrochloride), the duration of analgesia by peripheral nerve block was significantly higher as compared with the placebo group (p < 0.000001). Methylprednisolone 37-55 C-reactive protein Homo sapiens 91-94 32061400-8 2020 Postoperative levels of C-reactive protein were less in the methylprednisolone group (P = .039). Methylprednisolone 60-78 C-reactive protein Homo sapiens 24-42 29208852-10 2017 Therefore, methylprednisolone 500 mg/day for 3 days was started followed by prednisolone 30 mg/day and immunosuppressive agent (Cyclosporine 50 mg/day), which improved her general condition, elevated C-reactive protein levels, and extremely high serum ferritin levels. Methylprednisolone 11-29 C-reactive protein Homo sapiens 200-218 28744857-8 2017 Finally, methylprednisolone reduced the C-reactive protein response 24 h postoperatively; 31.1 (1.1) mg.l-1 vs. 68.4 (1.1) mg.l-1 , p < 0.001. Methylprednisolone 9-27 C-reactive protein Homo sapiens 40-58 28744857-9 2017 Pre-operative administration of methylprednisolone 125 mg reduced circulating markers of endothelial activation and damage, as well as the systemic inflammatory response (C-reactive protein) early after fast-track total knee arthroplasty. Methylprednisolone 32-50 C-reactive protein Homo sapiens 171-189